| Literature DB >> 25501441 |
Fernanda Machado Balzan1, Régis Chiarelli da Silva2, Danton Pereira da Silva3, Paulo Roberto Stefani Sanches3, Angela Maria Vicente Tavares4, Jorge Pinto Ribeiro1, Danilo Cortozi Berton5, Nadine Oliveira Clausell6.
Abstract
The main objective was to assess the effects of abdominal breathing (AB) versus subject's own breathing on femoral venous blood flow (Qfv) and their repercussions on central hemodynamics at rest and during exercise contrasting healthy subjects versus heart failure (HF) patients. We measured esophageal and gastric pressure (PGA), Qfv and parameters of central hemodynamics in eight healthy subjects and nine HF patients, under four conditions: subject's own breathing and AB ( ∆: PGA ≥ 6 cmH2O) at rest and during knee extension exercises (15% of 1 repetition maximum) until exhaustion. Qfv and parameters of central hemodynamics [stroke volume (SV), cardiac output (CO)] were measured using Doppler ultrasound and impedance cardiography, respectively. At rest, healthy subjects Qfv, SV, and CO were higher during AB than subject's breathing (0.11 ± 0.02 vs. 0.06 ± 0.00 L·min(-1), 58.7 ± 3.4 vs. 50.1 ± 4.1 mL and 4.4 ± 0.2 vs. 3.8 ± 0.1 L·min(-1), respectively, P ≤ 0.05). ∆SV correlated with ∆PGA during AB (r = 0.89, P ≤ 0.05). This same pattern of findings induced by AB was observed during exercise (SV: 71.1 ± 4.1 vs. 65.5 ± 4.1 mL and CO: 6.3 ± 0.4 vs. 5.2 ± 0.4 L·min(-1); P ≤ 0.05); however, Qfv did not reach statistical significance. The HF group tended to increase their Qfv during AB (0.09 ± 0.01 vs. 0.07 ± 0.03 L·min(-1), P = 0.09). On the other hand, unlike the healthy subjects, AB did not improve SV or CO neither at rest nor during exercise (P > 0.05). In healthy subjects, abdominal pump modulated venous return improved SV and CO at rest and during exercise. In HF patients, with elevated right atrial and vena caval system pressures, these findings were not observed.Entities:
Keywords: Cardiac output; diaphragmatic contraction; venous return
Year: 2014 PMID: 25501441 PMCID: PMC4332204 DOI: 10.14814/phy2.12216
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Figure 1.Flowchart of the experimental protocol Dotted squares indicating the moment of the physiological measurements. Subjects were instructed to continue until exhaustion.
Characteristics of study participants
| Characteristics | Healthy subjects ( | HF group ( |
|---|---|---|
| Demographic/anthropometric | ||
| Age, y | 57.4 ± 9.4 | 60.4 ± 6.7 |
| Weight, kg | 81.2 ± 10.7 | 74.9 ± 14.9 |
| Height, cm | 174.3 ± 0.1 | 167.8 ± 0.07 |
| BMI, kg m−3 | 26.3 ± 1.9 | 26.9 ± 4.1 |
| RR, breaths per minute | 14 ± 2 | 17 ± 3 |
| HR, bpm | 67 ± 6 | 71 ± 21 |
| SBP, mm Hg | 131 ± 10 | 118 ± 27 |
| DBP, mm Hg | 78 ± 6 | 75 ± 14 |
| LVEF, % | 33 ± 9 | |
| NYHA Class | I = 3 II = 6 | |
| Weber Class | A = 8 B = 1 | |
| Etiology (hypertensive/alcohol/ischem/idiop) | 1 / 2 / 5 / 1 | |
| Comorbidities (HSP/hepatitis A/ DM II) | 3 / 1 / 4 | |
| Smoking history (no/yes) | 6/2 | 2/7 |
| Pulmonary function | ||
| FEV1, L | 3.24 ± 0.4 | 2.0 ± 0.5 |
| FEV1, % predicted | 90.0 ± 13.1 | 85.0 ± 14.7 |
| FVC, L | 4.2 ± 0.7 | 2.8 ± 0.4 |
| FVC, % predicted | 104.2 ± 11.7 | 75.8 ± 15.9 |
| FEV1 / FVC | 0.77 ± 3.9 | 0.71 ± 15.6 |
| FEV1 / FVC, % predicted | 97.9 ± 4.9 | 90.3 ± 19.4 |
| Peak exercise data | ||
| 36.0 ± 6.0 | 24.7 ± 9.0 | |
| RER | 1.19 ± 0.09 | 1.15 ± 0.07 |
| VE/VCO2 slope | 21.0 ± 11.3 | 36.6 ± 4.4 |
| Muscle strength | ||
| 114.1 ± 24.1 | 93.2 ± 16.9 | |
| 106.4 ± 18.7 | 86.0 ± 14.7 | |
| 148.4 ± 20.4 | 105.5 ± 44.2 | |
| 126.1 ± 19.6 | 93.4 ± 39.9 | |
| Sn | 105 ± 33 | 71 ± 22 |
| Sn | −68 ± 23 | −56 ± 14 |
| Knee extensor, Load 1RM, kg | 97.6 ± 19.3 | 48.5 ± 10.8 |
| Medication | % Using | |
| Digoxin | 66.70 | |
| Diuretics | 88.90 | |
| Long‐acting nitrates | 33.30 | |
| Statins | 66.70 | |
| Aspirin | 44.40 | |
| Beta‐blockers | 100 | |
| ACE inhibitors | 88.90 | |
BMI, body mass index; RR, respiratory rate; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association Functional Classification; HSP, high systolic pressure; FEV, forced expiratory volume in 1 sec; FVC, forced vital capacity; VO2peak, peak oxygen uptake; RER, respiratory exchange ratio; VE, minute volume; SnPDI, sniff transdiaphragmatic pressure; SnP, sniff esophageal; 1RM, 1 repetition maximal; ACE inhibitors, angiotensin‐converting‐enzyme inhibitors.
% in use.
Ventilatory, metabolic and circulatory parameters according breathing pattern at rest and during knee extension exercise
| Parameter measured | At rest | Exercise | ||
|---|---|---|---|---|
| Subject's breathing | Abdominal breathing | Subject's breathing | Abdominal breathing | |
| Controls | 1.3 ± 0.2 | 1.5 ± 0.1 | 1.5 ± 0.2 | 1.9 ± 0.2 |
| HF group | 1.1 ± 0.1 | 1.4 ± 0.2 | 1.2 ± 0.2 | 1.6 ± 0.2 |
| BF (1 min−1) | ||||
| Controls | 17 ± 2.0 | 16 ± 0.9 | 18 ± 0.0 | 16 ± 0.0 |
| HF group | 14 ± 0.8 | 14 ± 0.9 | 18 ± 1.3 | 18 ± 2.6 |
| Controls | 21.4 ± 5.9 | 26.0 ± 3.0 | 31.9 ± 4.7 | 37.1 ± 5.8 |
| HF group | 14.7 ± 1.1 | 20.0 ± 2.4 | 23.0 ± 2.7 | 26.8 ± 2.3 |
| Controls | 122.7 ± 4.2 | 131.7 ± 2.8 | 119.0 ± 4.0 | 121.1 ± 2.8 |
| HF group | 123.3 ± 2.9 | 128.0 ± 3.8 | 121.3 ± 3.1 | 121.3 ± 3.4 |
| Controls | 24.4 ± 2.6 | 19.0 ± 1.7 | 26.4 ± 2.6 | 24.4 ± 2.1 |
| HF group | 24.7 ± 1.9 | 21.6 ± 2.4 | 24.4 ± 2.2 | 24.1 ± 2.2 |
| Controls | 4.5 ± 0.8 | 4.6 ± 0.6 | 7.7 ± 0.6 | 9.1 ± 0.5 |
| HF group | 3.7 ± 0.3 | 3.6 ± 0.3 | 6.3 ± 0.5 | 7.3 ± 0.5 |
| Mean blood pressure (mmHg) | ||||
| Controls | 97 ± 4 | 96 ± 2 | 93 ± 5 | 98 ± 1 |
| HF group | 88 ± 5 | 86 ± 5 | 93 ± 7 | 89 ± 5 |
| Heart rate (1 min−1) | ||||
| Controls | 80 ± 6 | 83 ± 7 | 98 ± 7 | 96 ± 4 |
| HF group | 76 ± 5 | 79 ± 5 | 82 ± 6 | 81 ± 6 |
VT, volume tidal; BF, breathing rate; V’E, minute ventilation; PETO2, end‐tidal oxygen tension; PETCO2, end‐tidal carbon dioxide tension; VO2·kg−1, oxygen uptake in milliliters of oxygen per kilogram of bodyweight per minute; VO2, absolute oxygen uptake; METS, metabolic equivalent.
P ≤ 0.05 between subject's breathing and abdominal breathing.
Figure 2.Femoral venous blood flow and central hemodynamic parameters for breathing patterns at rest and during knee extension exercise in healthy controls (A) and HF patients group (B). Data presented in media and standard error. *P ≤ 0.05 between the subject's breathing and abdominal breathing.
Figure 3.Pearson correlation between the differences in gastric pressure (PGA) and stroke volume (SV) at rest in the healthy controls group.
Clinical outcomes according to breathing pattern at peak knee extension exercise
| Variable | Subject's breathing | Abdominal breathing | |
|---|---|---|---|
| Tlim (min) | |||
| Controls | 8.6 ± 1.0 | 9.4 ± 0.6 | 0.196 |
| HF group | 10.6 ± 1.9 | 6.0 ± 0.7* | 0.017 |
| Leg Effort (Borg) per Tlim | |||
| Controls | 0.71 ± 0.18 | 0.44 ± 0.07 | 0.090 |
| HF group | 0.67 ± 0.23 | 1.51 ± 0.31* | 0.040 |
| Dyspnea (Borg) per Tlim | |||
| Controls | 0.35 ± 0.13 | 0.29 ± 0.10 | 0.636 |
| HF group | 0.53 ± 0.16 | 1.04 ± 0.22 | 0.080 |
Tlim, time to the limit of tolerance; HF, heart failure. *P ≤ 0.05 between subject's breathing and abdominal breathing.